NEWS
News Articles
EPA, FDA and USDA Issues Updates to the Joint Regulatory Plan for Biotechnology
Contact Information: EPA Press Office (press@epa.gov) Source: https://www.epa.gov/newsreleases/epa-fda-and-usda-issues-updates-joint-regulatory-plan-biotechnology WASHINGTON – Today, May 8, 2024, in response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration and the U.S. Department of Agriculture have developed a plan to update, streamline…
Read MoreRadyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies into the U.S. Market
Source: Radyus/PR Newswire ATLANTA, May 7, 2024 /PRNewswire/ — Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract research organization (CRO). This collaboration aims to assist South Korean biotech companies in entering the U.S. market by offering integrated services for drug development…
Read More6 Cornerstone Truths for Medtech Innovators (Researchers or Clinicians) in the Hospital Setting
By: Marty Jacobson with Paul Snyder | GCMI Source-GCMI Because clinicians have such an intimate knowledge of unmet clinical needs, hospitals are fertile ground for medtech innovations that improve value and outcomes. But bringing a technology or device to bear in clinical use, especially at any scale, works in much different, much more rigorous ways…
Read MoreAtlanta’s Biotech Scene Prepares for New Heights
Source: BioSpace A new project has capped off construction in Midtown Atlanta, providing physical real estate that experts say is sorely needed for the region’s growing biotech ecosystem, now home to more than 4,000 life science companies. The Science Square project completed the first phase of construction last week. Built by real estate developer Trammell Crow and Georgia Advanced Technology…
Read MoreAndson Biotech raises $3.6 million seed round
Source: Andson Bio ATLANTA, April 30, 2024 – Andson Biotech, a biotools company developing streamlined sample prep and data analytics solutions for mass spectrometry workflows, has successfully closed a $3.6 million round in equity financing. This capital will support hiring talent to accelerate the market introduction of its inline mass spec sample prep solution, DynaCHIP. This patented technology…
Read MoreAdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests
WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s final rule for Laboratory Developed Tests (LDTs): “We appreciate FDA’s commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardless of their source, which is what today’s rule…
Read More